Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Florida Trust Wealth Management Co Sells 4,244 Shares of Johnson & Johnson $JNJ
05:04am, Wednesday, 21'st Jan 2026
Florida Trust Wealth Management Co lessened its position in Johnson and Johnson (NYSE: JNJ) by 1.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The f
Johnson & Johnson $JNJ Shares Purchased by Harel Insurance Investments & Financial Services Ltd.
05:04am, Wednesday, 21'st Jan 2026
Harel Insurance Investments and Financial Services Ltd. boosted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 1,013.7% during the undefined quarter, according to the company in its most re
Donoghue Forlines LLC Grows Holdings in Johnson & Johnson $JNJ
05:04am, Wednesday, 21'st Jan 2026
Donoghue Forlines LLC grew its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 119.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
S&P 500 Records Worst Session Since October: Investor Sentiment Dips, Fear & Greed Index In 'Neutral' Zone
01:16am, Wednesday, 21'st Jan 2026
Market sentiment declined as Trump's trade stance intensified fears. CNN Fear and Greed index moved to 'Neutral' zone.
Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday
01:14am, Wednesday, 21'st Jan 2026
U.S. stock futures up, focus on JNJ earnings, GameStop CEO's stock purchase, Halliburton earnings, Netflix results.
Johnson & Johnson Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
01:07am, Wednesday, 21'st Jan 2026
Johnson & Johnson (NYSE: JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21.
Markets Switch to "Risk-Off" Ahead of Trump at Davos
07:17pm, Tuesday, 20'th Jan 2026
Off session lows by a whisker, the Dow shed -870 points, -1.76%, while the S&P 500 lost -43 points, -2.06%, and the tech-heavy Nasdaq dropped -561 points, -2.39%.
Market Today: Netflix's WBD Bid, Tech Selloff, AI at Davos
05:35pm, Tuesday, 20'th Jan 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in APYX by 1.27%Add in EBF by 4.13%New position in ANDGSmead Value Fund has made the foll
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings
08:37am, Tuesday, 20'th Jan 2026
Johnson & Johnson (NYSE: JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21.
NBT Bank N A NY Sells 3,984 Shares of Johnson & Johnson $JNJ
07:49am, Tuesday, 20'th Jan 2026
NBT Bank N A NY lessened its holdings in Johnson and Johnson (NYSE: JNJ) by 3.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 108,777 s
Johnson & Johnson $JNJ Shares Sold by QRG Capital Management Inc.
07:49am, Tuesday, 20'th Jan 2026
QRG Capital Management Inc. decreased its holdings in Johnson and Johnson (NYSE: JNJ) by 34.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and
Johnson & Johnson's $10 Billion Test: 2026 Outlook Could Make Or Break JNJ Heading Into Q4
04:11am, Tuesday, 20'th Jan 2026
Johnson and Johnson is set to report its Q4 results on Wednesday, facing one of the most important transitions in its modern history.
Rep. Thomas H. Kean, Jr. Shares of Liberty Media Corporation – Liberty Live Series C (NASDAQ:LLYVK)
02:25am, Tuesday, 20'th Jan 2026
Representative Thomas H. Kean, Jr. (R-New Jersey) recently bought shares of Liberty Media Corporation - Liberty Live Series C (NASDAQ: LLYVK). In a filing disclosed on January 16th, the Representative
Rep. Thomas H. Kean, Jr. Liberty Media Corporation – Liberty Live Series A (NASDAQ:LLYVA) Stock
02:23am, Tuesday, 20'th Jan 2026
Representative Thomas H. Kean, Jr. (R-New Jersey) recently bought shares of Liberty Media Corporation - Liberty Live Series A (NASDAQ: LLYVA). In a filing disclosed on January 16th, the Representative
Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results?
10:10am, Monday, 19'th Jan 2026
JNJ heads into Q4 earnings with strong pharma and MedTech momentum, offset by Stelara biosimilar pressure and China-related headwinds.
